We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

18 hedge funds and large institutions have $103K invested in AIM ImmunoTech in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

38% more funds holding

Funds holding: 13 → 18 (+5)

1.65% more ownership

Funds ownership: 3.72% → 5.36% (+1.6%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

14% less capital invested

Capital invested by funds: $120K → $103K (-$16.9K)

Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$51.6K
2
HF
HRT Financial
New York
+$26.4K
3
XT
XTX Topco
Cayman Islands
+$20.9K
4
Jane Street
Jane Street
New York
+$20.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$12.7K

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$78.6K
2
UBS Group
UBS Group
Switzerland
-$383
3
Bank of America
Bank of America
North Carolina
-$32
4
Morgan Stanley
Morgan Stanley
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$30K +$51.6K +50,895 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$17.5K +$12.7K +12,525 +72%
HF
3
HRT Financial
New York
$15K +$26.4K +26,032 New
XT
4
XTX Topco
Cayman Islands
$12K +$20.9K +20,590 New
Jane Street
5
Jane Street
New York
$11.7K +$20.3K +20,047 New
VFT
6
Vanguard Fiduciary Trust
Pennsylvania
$10.2K +$17.7K +17,519 New
NA
7
NewEdge Advisors
Louisiana
$2.92K +$5.07K +5,000 New
TRCT
8
Tower Research Capital (TRC)
New York
$2.73K +$4.6K +4,543 +3,634%
Morgan Stanley
9
Morgan Stanley
New York
$505 -$1 -1 -0.1%
CB
10
Community Bank
New York
$76 – – –
HI
11
Harbour Investments
Wisconsin
$19 +$32 +32 New
CFD
12
Creative Financial Designs
Indiana
$18 +$30 +30 New
Osaic Holdings
13
Osaic Holdings
Arizona
$7 – – –
HI
14
Hoey Investments
Pennsylvania
$6 – – –
UBS Group
15
UBS Group
Switzerland
$1 -$383 -378 -100%
FFA
16
Farther Finance Advisors
California
$1 – – –
ISWM
17
Intesa Sanpaolo Wealth Management
$1 – – –
SPIA
18
Steward Partners Investment Advisory
New York
$1 – – –
DS
19
DRW Securities
Illinois
– -$78.6K -69,615 Closed
Bank of America
20
Bank of America
North Carolina
– -$32 -28 Closed

AIM Hedge Fund Activity: Q1 2026 in Review

18 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2026, worth a combined $103K — down 14% from $120K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AIM positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $51.6K. The largest seller was DRW Securities, exiting entirely with an estimated $78.6K sold.

  • 18 institutional investors held AIM ImmunoTech (AIM) as of Q1 2026, up from 13 in Q4 2025.
  • Funds reported $103K of AIM ImmunoTech stock for Q1 2026, down 14% quarter-over-quarter.
  • 8 funds opened new AIM ImmunoTech positions in Q1 2026 and 2 closed out, a net change of +6 holders.
  • The largest AIM ImmunoTech buyer in Q1 2026 was Virtu Financial, an estimated $51.6K added.
  • The largest AIM ImmunoTech seller in Q1 2026 was DRW Securities, an estimated $78.6K sold.

Based on aggregated 13F filings for Q1 2026.